Lubiprostone
These highlights do not include all the information needed to use LUBIPROSTONE CAPSULES safely and effectively. See full prescribing information for LUBIPROSTONE CAPSULES. LUBIPROSTONE capsules, for oral use Initial U.S. Approval: 2006
9d958b58-6c4f-4bb1-8660-cf5eac256440
HUMAN PRESCRIPTION DRUG LABEL
Apr 13, 2021
Par Pharmaceutical Inc.
DUNS: 092733690
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Lubiprostone
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
Lubiprostone
Product Details
FDA regulatory identification and product classification information